⌘K

Login Start Free

Home/Insiders/Martell Christopher

MC

SEC Insider//CIK 0001873465

Martell Christopher

CIK 00018734651 companyNEEDHAM, MA

Transactions

12

Companies

1

Filings

8

CIK

0001873465

Recent Transactions

12 trades

Award
Candel Therapeutics, Inc.$CADL
Common Stock
2025-06-25$4.67/sh+111,349→ 111,349 total
Award
Candel Therapeutics, Inc.$CADL
Stock Option (Right to Buy)
2025-06-17+14,240→ 14,240 total
Award
Candel Therapeutics, Inc.$CADL
Stock Option (Right to Buy)
2024-06-26+14,240→ 14,240 total
Award
Candel Therapeutics, Inc.$CADL
Stock Option (Right to Buy)
2023-06-28+14,240→ 14,240 total
Purchase
Candel Therapeutics, Inc.$CADL
Common Stock
2022-12-09$1.92/sh+23,950→ 152,000 total
Purchase
Candel Therapeutics, Inc.$CADL
Common Stock
2022-12-09$1.92/sh+23,950→ 152,000 total
Purchase
Candel Therapeutics, Inc.$CADL
Common Stock
2022-12-08$1.68/sh+3,050→ 128,050 total
Purchase
Candel Therapeutics, Inc.$CADL
Common Stock
2022-12-08$1.68/sh+3,050→ 128,050 total
Award
Candel Therapeutics, Inc.$CADL
Stock Option (Right to Buy)
2022-10-13+14,240→ 14,240 total
Conversion
Candel Therapeutics, Inc.$CADL
Common Stock
2021-07-29+283,514→ 283,514 total
Conversion
Candel Therapeutics, Inc.$CADL
Series B Preferred Stock
2021-07-29−696,851→ 0 total
Purchase
Candel Therapeutics, Inc.$CADL
Common Stock
2021-07-29$8.00/sh+125,000→ 125,000 total

Companies

1

Candel Therapeutics, Inc.
Director
$CADL

Recent Filings

8

Address

C/O CANDEL THERAPEUTICS, INC. 117 KENDRICK ST., SUITE 450

NEEDHAM, MA, 02494

View on SEC.gov